We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
251
Dianthus Therapeutics
DNTH
$5.69B
$11.9M 0.06%
301,428
+60,852
+25% +$1.56M
HON icon
252
Honeywell
HON
$76.4B
$11.9M 0.06%
59,756
+3,449
+6% +$721K
MGA icon
253
Magna International
MGA
$18.8B
$11.7M 0.06%
246,387
+94,851
+63% +$4.18M
APD icon
254
Air Products & Chemicals
APD
$65.5B
$11.6M 0.06%
42,684
-5,434
-11% -$1.57M
ACAD icon
255
Acadia Pharmaceuticals
ACAD
$4.51B
$11.5M 0.06%
+537,601
New +$12.7M
SBUX icon
256
Starbucks
SBUX
$119B
$11.4M 0.06%
134,762
+1,632
+1% +$146K
PODD icon
257
Insulet
PODD
$11.8B
$11.2M 0.06%
36,277
-40,485
-53% -$12.7M
PLD icon
258
Prologis
PLD
$136B
$11.2M 0.06%
97,773
-4,693
-5% -$516K
LRN icon
259
Stride
LRN
$4.16B
$11M 0.06%
73,598
-92,548
-56% -$13.6M
MWA icon
260
Mueller Water Products
MWA
$3.94B
$10.9M 0.06%
427,684
-76,659
-15% -$1.96M
KYMR icon
261
Kymera Therapeutics
KYMR
$8.66B
$10.8M 0.06%
191,639
+37,536
+24% +$1.69M
DECK icon
262
Deckers Outdoor
DECK
$14.1B
$10.8M 0.06%
106,083
-8
-0% -$873
GH icon
263
Guardant Health
GH
$19.1B
$10.7M 0.06%
171,753
+1,231
+0.7% +$67K
LENZ
264
LENZ Therapeutics
LENZ
$179M
$10.7M 0.06%
228,942
+57,668
+34% +$2.12M
SMMT icon
265
Summit Therapeutics
SMMT
$10.2B
$10.6M 0.06%
513,763
– –
NKE icon
266
Nike
NKE
$64.1B
$10.6M 0.06%
151,364
-233,934
-61% -$17.4M
DYN icon
267
Dyne Therapeutics
DYN
$4.15B
$10.5M 0.06%
833,922
+309,761
+59% +$3.53M
IR icon
268
Ingersoll Rand
IR
$33.1B
$10.5M 0.06%
127,602
+34,004
+36% +$2.79M
IEX icon
269
IDEX
IEX
$17B
$10.5M 0.05%
64,246
-1,397
-2% -$236K
URI icon
270
United Rentals
URI
$65.7B
$10.4M 0.05%
10,899
+209
+2% +$186K
SQM icon
271
Sociedad Química y Minera de Chile
SQM
$19.3B
$10.3M 0.05%
+238,882
New +$9.96M
WPC icon
272
W.P. Carey
WPC
$16.6B
$10.2M 0.05%
151,305
+3,756
+3% +$246K
DE icon
273
Deere & Co
DE
$165B
$10.2M 0.05%
22,222
-11,598
-34% -$5.72M
NXT icon
274
Nextpower Inc
NXT
$14.1B
$10.1M 0.05%
136,799
+25,594
+23% +$1.65M
INTC icon
275
Intel
INTC
$413B
$10.1M 0.05%
301,452
-8,943
-3% -$217K
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.